There have been some reports on the efficacy and tolerability of an oral itraconazole (ITCZ) solution as prophylaxis for fungal infection in patients with hematological malignancies. However, there are some cases where the bitter taste of oral ITCZ solution leads to an interruption of administration because the patient refuses to take this medicine. Therefore, we prospectively investigated the pharmacokinetics and promotion of treatment adherence in patients taking oral ITCZ solution mixed with a beverage. Compared with the responses of patients taking oral ITCZ solution with water, the taste of the agent was improved significantly when mixed with orange juice, although the plasma concentration of the agent did not differ between the two groups. Using this method, we can expect an improvement in treatment adherence and this method can easily be applied in clinical practice. This method is highly useful and should become common knowledge.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Increased trough concentration of venetoclax when combined with itraconazole for acute myeloid leukemia.
Ann Hematol
November 2024
Department of Hematology, Eiju General Hospital, 2-23-16 Higashiueno, Taito-ku, Tokyo, 110-8645, Japan.
Article Synopsis
- Venetoclax (Ven) combined with azacitidine (Aza) was administered to 34 patients with acute myeloid leukemia (AML) for treatment purposes, with half receiving itraconazole oral solution (ITCZ-OS) for antifungal prevention.
- Patients who received ITCZ had significantly higher levels of Ven in their blood compared to those who did not, with some having dangerously high concentrations.
- Measuring Ven levels in patients, especially those on antifungal treatment, is crucial for improving clinical outcomes, as higher concentrations were linked to better response rates in achieving complete remissions.
We compared the minimum inhibitory concentrations (MICs) and minimum fungicidal concentrations (MFCs) of azoles in antifungal drug-susceptible, terbinafine-resistant, and lowly itraconazole (ITCZ)-susceptible strains of dermatophytes. To assess the MICs of ITCZ, ravuconazole (RVCZ), efinaconazole (EFCZ), and luliconazole (LUCZ) in the isolates, broth microdilution assays were performed based on the Clinical and Laboratory Standards Institute M38-A2 guidelines with modifications. After the assays for determining the MICs, the inoculum suspensions in wells were resuspended, then 10 μL of the growth solution in each well was inoculated onto potato dextrose agar with the use of a pipette.
View Article and Find Full Text PDFImproved absorption of itraconazole tablet by co-administration with lemon beverages in a lung transplant recipient: A case report.
J Infect Chemother
August 2022
Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, 54 Shogoin- Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan. Electronic address:
After lung transplantation, itraconazole (ITCZ) is used as a prophylaxis for aspergillosis. ITCZ is a weak base with high lipophilicity, and the dissolution and absorption of ITCZ tablets and capsules are pH dependent. Therefore, ITCZ may not achieve sufficient serum concentrations in patients with higher gastric pH because of its poor bioavailability.
View Article and Find Full Text PDFCosine similarity as a sample size-free measure to quantify phase clustering within a single neurophysiological signal.
J Neurosci Methods
February 2018
Imaging Center for integrated Body, Mind, and Culture Research, National Taiwan University, Taipei, Taiwan, ROC. Electronic address:
Background: Phase clustering within a single neurophysiological signal plays a significant role in a wide array of cognitive functions. Inter-trial phase coherence (ITC) is commonly used to assess to what extent phases are clustered in a similar direction over samples. However, this measure is especially dependent on sample size.
View Article and Find Full Text PDFPlasma Concentration of Itraconazole in Patients With Hematologic Malignancies Treated With Itraconazole Oral Solution.
Ther Drug Monit
June 2017
*Department of Internal Medicine, Tokyo Metropolitan Ohtsuka Hospital, Tokyo; †Department of Hematology, Nippon Medical School, Tokyo; and ‡Department of Hematology, Kanazawa University Hospital, Kanazawa, Japan.
Background: The prophylactic administration of itraconazole (ITCZ) is effective for preventing mycotic infections during chemotherapy in patients with hematologic malignancies. However, fungal infections can occur when the ITCZ does not reach an effective concentration.
Methods: We conducted a prospective study to monitor the plasma concentration of ITCZ and hydroxyl-ITCZ (OH-ITCZ) weekly and to verify whether the day 3 plasma concentration of ITCZ could predict the subsequent acquisition of an effective plasma concentration.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!